LEADER 01731oam  2200433   450 
001 9910704708903321
005 20131205115611.0
035   $a(CKB)5470000002444640
035   $a(OCoLC)856545318
035   $a(EXLCZ)995470000002444640
100   $a20130821d2013      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFDA user fees 2012 $eissues related to accelerated approval, medical gas, antibiotic development, and downstream pharmaceutical supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, March 8, 2012
210  1$aWashington :$cU.S. Government Printing Office,$d2013.
215   $a1 online resource (iv, 214 pages) $cillustrations
300   $aTitle from title screen (viewed on Aug. 21, 2013).
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.
300   $a"Serial no. 112-126."
320   $aIncludes bibliographical references.
517   $aFDA user fees 2012 
606   $aDrug approval$zUnited States
606   $aGases$xTherapeutic use$xGovernment policy$zUnited States
606   $aAntibiotics$xDevelopment$zUnited States
606   $aDrugs$zUnited States$xMarketing
615  0$aDrug approval
615  0$aGases$xTherapeutic use$xGovernment policy
615  0$aAntibiotics$xDevelopment
615  0$aDrugs$xMarketing.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910704708903321
996   $aFDA user fees 2012$93463567
997   $aUNINA

LEADER 00404nam  2200169z- 450 
001 996555033403316
035   $a(CKB)4920000003050930
035   $a(EXLCZ)994920000003050930
100   $a20231031cuuuuuuuu  -u-            -
101 0 $aeng
200 04$aThe Star (Kenya)
210   $aKenya
517   $aStar 
906   $aDOCUMENT
912   $a996555033403316
996   $aThe Star (Kenya)$93576836
997   $aUNISA